This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why You Should Retain CNO Financial (CNO) in Your Portfolio
by Zacks Equity Research
Riding on technology and cost-curbing measures, CNO Financial (CNO) holds potential to reap benefits for investors.
MGIC Investment (MTG) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
MGIC Investment (MTG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Is CNO Financial (CNO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
MetLife's (MET) third-quarter results reflect sound underwriting results and reduced costs, partly offset by muted revenues.
Radian Group (RDN) Q3 Earnings Beat Estimates, Tumble Y/Y
by Zacks Equity Research
Radian Group's (RDN) third-quarter results reflect strong housing market leading to higher mortgage insurance business written, partly offset by higher loss provision.
CNO Financial's (CNO) Q3 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
CNO Financial's (CNO) third-quarter 2020 results reflect improving revenues and reduced expenses, partly offset by decline in annuity collected premiums.
CNO Financial (CNO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 71.74% and 17.97%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
6 Multiline Insurers to Watch Out for Amid Operational Challenges
by Tanuka De
Better pricing, product redesigns and increased adoption of technology are expected to aid multiline insurers like CI, MET, CNO, HMN, ORI, and MTG. However, a low-rate environment remains a headwind.
Insurance Stock Q3 Earnings Roster for Nov 2: AIZ, CNA & More
by Tanuka De
Third-quarter results AIZ, CNA, KMPR, CNO and HMN are likely to reflect improved pricing, strong retention, and new business, partially offset by cat losses and lower interest rate.
Why Earnings Season Could Be Great for CNO Financial (CNO)
by Zacks Equity Research
CNO Financial (CNO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in the Cards for Assurant (AIZ) This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) Q3 results are likely to reflect higher claims activity in Connected Living, mobile seasonality and lower mortality risk.
Prudential (PRU) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q3 results are likely to reflect the re-pricing of products and shift toward lower risk and less capital-intensive products.
What's in Store for Hartford Financial (HIG) Q3 Results?
by Zacks Equity Research
Hartford Financial's (HIG) Q3 results to reflect muted revenues and weak performances at both its Personal Lines and Commercial businesses.
CNO Financial (CNO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CNO (CNO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Everest Re Group (RE) to Report Q3: What's in the Cards?
by Zacks Equity Research
Everest Re (RE) Q3 earnings are likely to have benefited from strong renewal retention and better pricing though cat loss to weigh on underwriting profit.
Chubb Limited (CB) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Chubb Limited's (CB) Q3 earnings is likely to benefit from higher premiums, though cat loss will weigh on underwriting volatility.
Will Aflac (AFL) Maintain its Beat Streak in Q3 Earnings?
by Zacks Equity Research
Aflac's (AFL) Aflac Japan and U.S. segments are expected to have seen strained revenues in Q3 due to COVID-19-led business disruption.
Why CNO (CNO) Could Beat Earnings Estimates Again
by Zacks Equity Research
CNO (CNO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What Awaits Cincinnati Financial (CINF) in Q3 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) Q3 results are likely to reflect cat loss and deterioration in combined ratio. However, better premiums are likely to have limited the downside.
Why CNO Financial (CNO) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Brown & Brown (BRO) Rewards Shareholders With Dividend Hike
by Zacks Equity Research
Brown & Brown's (BRO) recent dividend hike highlights strong financial position and constant efforts to enhance shareholders' value.
Should Value Investors Buy CNO Financial (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
W.R. Berkley (WRB) to Report Q3 Earnings: What's in Strore?
by Zacks Equity Research
W. R. Berkley's (WRB) third-quarter results are likely to reflect lower premiums and weak investment income due to the COVID-19 pandemic.
Travelers (TRV) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Travelers' (TRV) Q3 earnings are likely to have benefited from increase in premiums, partially offset by catastrophe losses.
7 Insurers Poised to Beat Estimates This Earnings Season
by Tanuka De
Better pricing and underwriting practice, product repositioning and sturdy capital will help these insurers outperform Q3 earnings estimates.